The human IL-15 superagonist ALT-803 directs SIV-specific CD8(+) T cells into B-cell follicles. Feb 12, 2018 | Uncategorized
First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation. Feb 12, 2018 | Uncategorized
ALT-803 Transiently Reduces Simian Immunodeficiency Virus Replication in the Absence of Antiretroviral Treatment. Feb 1, 2018 | Uncategorized
Providing a Homing Receptor for CAR Engineered NK Cells – Improving Cellular Immunotherapy for B-Cell Lymphomas Jan 28, 2018 | Uncategorized
CD16(+)NK-92 and anti-CD123 monoclonal antibody prolongs survival in primary human acute myeloid leukemia xenografted mice Jan 28, 2018 | Uncategorized
